![logo](/logos/OGN.webp)
Organon & Co.
NYSE:OGN
20.49 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Organon & Co. |
Symbool | OGN |
Munteenheid | USD |
Prijs | 20.49 |
Beurswaarde | 5,275,621,770 |
Dividendpercentage | 5.25% |
52-weken bereik | 10.835 - 23.1 |
Industrie | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Mr. Kevin Ali |
Website | https://www.organon.com |
An error occurred while fetching data.
Over Organon & Co.
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)